RETRACTED ARTICLE: Comparison of 0.05% cyclosporine and 3% diquafosol solution for dry eye patients: a randomized, blinded, multicenter clinical trial

Table 4 Changes of Schirmer values between CN and DQ group

	0	4 weeks	12 weeks	Difference (0–4 weeks)^a	Difference (0–12 weeks)^a	P value (0–12 weeks)^b
CN	8.67 ± 6.30 (2.00~35.00)	9.50 ± 6.21 (0.00~30.00)	10.14 ± 6.13 (0.00~30.00)	0.83 ± 5.26 (−17.00~14.00)	1.47 ± 6.20 (−20.00~19.00)	0.0031
DQ	7.96 ± 5.55 (1.00~30.00)	9.52 ± 6.71 (0.00~30.00)	9.02 ± 5.59 (0.00~35.00)	1.56 ± 5.45 (−14.00~20.00)	1.06 ± 6.32 (−16.00~15.00)	0.0643
P value	0.3955	0.9754	0.3675	0.9214	0.8597

CN 0.05% cyclosporin nanoemusion (0.5 mg/mL), DQ 3% diquafosol sodium (30 mg/mL)
^aComparison between CN and DQ groups by Wilcoxon rank sum test
^bComparison among three groups by Kruskal-Wallis test

ISSN: 1471-2415